Literature DB >> 26782974

Targeting CD8(+) T cells prevents psoriasis development.

Paola Di Meglio1, Federica Villanova2, Alexander A Navarini3, Alessio Mylonas4, Isabella Tosi2, Frank O Nestle2, Curdin Conrad5.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26782974     DOI： 10.1016/j.jaci.2015.10.046

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  43 in total

Review 1.  Autoimmunity and autoimmune co-morbidities in psoriasis.

Authors:  Kazuhisa Furue; Takamichi Ito; Gaku Tsuji; Takafumi Kadono; Takeshi Nakahara; Masutaka Furue
Journal:  Immunology       Date:  2018-02-06       Impact factor: 7.397

Review 2.  Psoriasis: a mixed autoimmune and autoinflammatory disease.

Authors:  Yun Liang; Mrinal K Sarkar; Lam C Tsoi; Johann E Gudjonsson
Journal:  Curr Opin Immunol       Date:  2017-07-22       Impact factor: 7.486

Review 3.  Psoriasis: Past, Present, and Future.

Authors:  Allison C Billi; Johann E Gudjonsson; John J Voorhees
Journal:  J Invest Dermatol       Date:  2019-11       Impact factor: 8.551

4.  Discovery of Selective Inhibitors of Endoplasmic Reticulum Aminopeptidase 1.

Authors:  Zachary Maben; Richa Arya; Digamber Rane; W Frank An; Shailesh Metkar; Marc Hickey; Samantha Bender; Akbar Ali; Tina T Nguyen; Irini Evnouchidou; Roger Schilling; Efstratios Stratikos; Jennifer Golden; Lawrence J Stern
Journal:  J Med Chem       Date:  2019-12-30       Impact factor: 7.446

5.  ERAP1 Controls the Autoimmune Response against Melanocytes in Psoriasis by Generating the Melanocyte Autoantigen and Regulating Its Amount for HLA-C*06:02 Presentation.

Authors:  Akiko Arakawa; Emma Reeves; Sigrid Vollmer; Yukiyasu Arakawa; Mengwen He; Adrian Galinski; Julia Stöhr; Klaus Dornmair; Edward James; Jörg C Prinz
Journal:  J Immunol       Date:  2021-09-27       Impact factor: 5.422

Review 6.  Barrier lymphocytes in spondyloarthritis.

Authors:  Adam Berlinberg; Kristine A Kuhn
Journal:  Curr Opin Rheumatol       Date:  2020-07       Impact factor: 5.006

Review 7.  Psoriasis: from Pathogenesis to Targeted Therapies.

Authors:  Curdin Conrad; Michel Gilliet
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

Review 8.  Anti-IL-17 Agents in the Treatment of Axial Spondyloarthritis.

Authors:  Fabiola Atzeni; Antonio Carriero; Laura Boccassini; Salvatore D'Angelo
Journal:  Immunotargets Ther       Date:  2021-05-03

9.  IFN-κ Is a Rheostat for Development of Psoriasiform Inflammation.

Authors:  Mehrnaz Gharaee-Kermani; Shannon N Estadt; Lam C Tsoi; Sonya J Wolf-Fortune; Jianhua Liu; Xianying Xing; Jonathon Theros; Tamra J Reed; Lori Lowe; Dennis Gruszka; Nicole L Ward; Johann E Gudjonsson; J Michelle Kahlenberg
Journal:  J Invest Dermatol       Date:  2021-08-05       Impact factor: 8.551

10.  Large-Scale Imputation of KIR Copy Number and HLA Alleles in North American and European Psoriasis Case-Control Cohorts Reveals Association of Inhibitory KIR2DL2 With Psoriasis.

Authors:  Richard Ahn; Damjan Vukcevic; Allan Motyer; Joanne Nititham; David McG Squire; Jill A Hollenbach; Paul J Norman; Eva Ellinghaus; Rajan P Nair; Lam C Tsoi; Jorge Oksenberg; John Foerster; Wolfgang Lieb; Stephan Weidinger; Andre Franke; James T Elder; Eric Jorgenson; Stephen Leslie; Wilson Liao
Journal:  Front Immunol       Date:  2021-06-11       Impact factor: 8.786
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.